Dyno Therapeutics Competitors and Similar CompaniesClear all
Dyno Therapeutics's competitors and similar companies include Oxford BioTherapeutics, Orchard Therapeutics, Stealth BioTherapeutics and BigHat Biosciences.
 Dyno Therapeutics Dyno Therapeutics is a biotechnology company that provides AI-powered gene therapies. |  Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  BigHat Biosciences BigHat Biosciences is a biotechnology company that develops an antibody discovery and development platform. | |
Founding Date | Founding Date 2018 | Founding Date 2004 | Founding Date 2015 | Founding Date 2007 | Founding Date 2019 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Watertown, US HQ | Locations Milton, GB HQ San Jose, US | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Newton, US HQ Needham, US | Locations San Mateo, US HQ |
Employees | Employees 1041% decrease | Employees 504% increase | Employees 166 | Employees 592% decrease | Employees 1131% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £2.1m (FY, 2018) | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income (£6.5m) (FY, 2018) | Net income ($150.7m) (FY, 2022) | Net income ($52.5m) (FY, 2021) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 100m (about 5 years ago) | Latest funding round $ 10m (almost 11 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 19m (about 5 years ago) |
Total funding raised | Total funding raised $ 109m | Total funding raised $ 21.6m | Total funding raised $ 310.7m | Total funding raised $ 100m | Total funding raised $ 24.3m |
For sources of this data, please see the company profile
View Company Profiles
Oxford BioTherapeutics
HQ
Milton, GB
Employees
50↑ 4% increase
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
View companyOrchard Therapeutics
HQ
London, GB
Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View companyStealth BioTherapeutics
HQ
Newton, US
Employees
59↓ 2% decrease
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View companyBigHat Biosciences
HQ
San Mateo, US
Employees
113↑ 1% increase
BigHat Biosciences is a biotechnology company that develops an antibody discovery and development platform.
View company